Serum cytokines in human heart transplant recipients: Is there a relationship to rejection?

Transplantation

Volumn 62, Issue 4, 1996, Pages 480-491

  Grant, Simon C D ^a   Lamb, William R ^b   Brooks, Nicholas H ^a   Brenchley, Paul E C ^b   Hutchinson, Ian V ^c  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; GRAFT REJECTION; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL;

EID: 0029815043     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199608270-00010     Document Type: Article

References (38)

1. Hancock WW, Tanaka K, Salem HH, Tilney NL, Atkins RC, Kupiec-Weglinski. TNF as a mediator of cardiac transplant rejection, including effects on the intragraft protein C/protein S/thrombomodulin pathway. Transplant Proc 1991; 23: 235.
2. Wanders A, Wells AF, Larsson E, et al. Expression of an interferon gamma-like substance in normal and transplanted rat heart tissue. J Heart Lung Transplant 1992; 11: 142.
3. Arbustini E, Grasso M, Diegoli M, et al. Expression of tumor necrosis factor in human acute cardiac rejection. Am J Pathol 1991; 139: 709.
4. Zhao XM, Frist WH, Yeoh TK, Miller GG. Expression of cytokine genes in human cardiac allografts: correlation of IL-6 and transforming growth factor-beta (TGF-β) with histological rejection. Clin Exp Immunol 1993; 93: 448.
5. Baan CC, van Emmerik NEM, Balk AHMM, et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 1994; 97: 293.
6. Cunningham DA, Dunn MJ, Yacoub MH, Rose ML. Local production of cytokines in the human cardiac allograft. a sequential study. Transplantation 1994; 57: 1333.
7. Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor alpha and lymphotoxin enhances cardiac allograft survival in rats. Transplantation 1990; 50: 189.
8. Imagawa DK, Millis JM, Seu P, et al. The role of tumor necrosis factor in allograft rejection. III. Evidence that antiTNF antibody therapy prolongs survival in rats with acute rejection. Transplantation 1991; 51: 57.
9. Van Gelder T, Balk AHMM, Mochtar B, Weimar W. Reversal of graft rejection with monoclonal anti interleukin 2 receptor. Lancet 1992; 339: 873.
10. Eason JD, Wee S, Kawai T, et al. Inhibition of the effects of TNF in renal allograft recipients using recombinant human dimeric tumor necrosis factor receptors. Transplantation 1995; 59: 300.
11. Chollet-Martin S, Depoix JP, Hvass U, Pansard Y, Vissuzaine C, Gougerot-Pocedalo MA. Raised plasma levels of tumor necrosis factor in heart allograft rejection. Transplant Proc 1990; 22: 283.
12. Young JB, Windsor T, Smart FW, et al. Inability of isolated soluble interleukin 2 receptor levels to predict biopsy rejection scores after heart transplantation. Transplantation 1991; 51: 636.
13. Jordan SC, Czer L, Toyoda M, et al. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy. J Heart Lung Transplant 1993; 12: 333.
14. Fyfe A, Daly P, Galligan L, Pirc L, Feindel C, Cardella C. Coronary sinus sampling of cytokines after heart transplantation: evidence for macrophage activation and interleukin-4 production within the graft. J Am Coll Cardiol 1993; 21: 171.
15. Maury CPJ, Teppo AM. Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection. J Exp Med 1987; 166: 1132.
16. McLaughlin PJ, Aikawa AA, Davies HM, Bakran A, Sells RA, Johnson PM. Tumour necrosis factor in renal transplantation. Transplant Proc 1991; 23: 1289.
17. Van Oers MHJ, Van Der Heyden AAPAM, AArden LA. Interleukin 6 (IL6) in serum and urine of renal transplant recipients. Clin Exp Immunol 1988; 71: 14.
18. Kita Y, Iwaki Y, Demetris, Starzl TE. Evaluation of sequential serum interleukin-6 levels in liver allograft recipients. Transplantation 1994; 57: 1037.
19. Thai NL, Fu F, Qian S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation. Transplantation 1995; 59: 274.
20. Takeuchi T, Lowry RP, Koniezny B. Heart allografts in murine systems: the differential activation of Th2 like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
21. Grant SCD, Lamb WR, Yonan N, Brenchley PEC, Hutchinson IV. Use of different antithymocyte globulin preparations following cardiac transplantation: clinical responses and cytokine responses in vivo and in vitro. Transplantation 1995; 60: 684.
22. Lamb WR, Pumphrey RSH, Brenchley PEC. A peroxidase-linked enzyme immunoassay for tumour necrosis factor alpha utilizing alternative colorimetric or chemilumimetric substrates. J Immunol Methods 1992; 55: 215.
23. Newstead CG, Lamb WR, Brenchley PEC, Short CD. Serum and urine IL-6 and TNF alpha in renal transplant recipients with graft dysfunction. Transplantation 1993; 56: 831.
24. Opelz G. Correlation of HLA matching with kidney survival in patients with or without cyclosporine treatment. Transplantation 1985; 40: 240.
25. Cook DJ, Terasakei PI. Renal transplantation on the American Continent. In: Organ transplantation: current clinical and immunological concepts. London: Bailliere Tindall, 1989: 195.
26. Hutchinson IV. Immunological mechanisms of long-term graft acceptance. In: Paul L, Solez K, eds. Organ transplantation: long term results. New York: Dekker, 1992: 1.
27. Rizeq MN, Masek MA, Billingham ME. Acute rejection: significance of elapsed time after transplantation. J Heart Lung Transplant 1994; 13: 862.
28. Imagawa DK, Millis JM, Olthoff KM, et al. The role of tumor necrosis factor in allograft rejection. I. evidence that elevated levels of tumor necrosis factor alpha predict rejection following orthotopic liver transplantation. Transplantation 1990; 50: 219.
29. Dorge S-E, Roux-Lombard P, Dayer J-M, Koch K-M, Frei U, Lonnemann G. Plasma levels of tumor necrosis factor (TNF) and soluble TNF receptors in kidney transplant recipients. Transplantation 1994; 58: 1000.
30. Jordan SC, Marcheveski A, Ross D, Toyoda M, Waters PF. Serum interleukin 2 levels in lung transplant recipients: correlation with findings on transbronchial biopsy. J Heart Lung Transplant 1992; 11: 1001.
31. Young JB, Lloyd KS, Windsor NT, et al. Elevated soluble Interleukin 2 receptor levels early after heart transplantation and long term survival and development of coronary arteriopathy. J Heart Lung Transplant 1991; 10: 243.
32. McNally CM, Luckhurst E, Penny R. Cell free serum interleukin 2 receptor levels after heart transplantation. J Heart Lung Transplant 1991; 10: 769.
33. Grant SCD, Lamb WR, Hutchinson I, Brenchley PEC. Serum soluble adhesion molecules and cytokines in cardiac allograft rejection. Transplant Immunol 1994; 2: 321.
34. Lin H, Chensue SW, Strieter RM, et al. Antibodies against tumor necrosis factor prolong cardiac allograft survival in the rat. J Heart Lung Transplant 1992;11: 330.
35. Hancock WW, DiStefano R, Braun P, Schweizer RT, Tilney NL, Kupiec JW. Cyclosporine and antiinterleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms. Transplantation 1990; 49: 416.
36. Soulillou JP, Peyronnet P, LeMauff B, et al. Prevention of rejection of kidney transplants by monoclonal antibody directed against interleukin 2. Lancet 1987; i: 1339.
37. Otto G, Thies J, Manner M, et al. Monoclonal antibody to interleukin-2 receptor in liver graft rejection. Lancet 1990; 335: 1596.
38. Kroemer G, de Alboran IM, Gonzalo JA, Martinez-A C. Immunoregulation by cytokines. Crit Rev Immunol 1993; 13: 163.